Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair (AURA)
Primary Purpose
Defect of Articular Cartilage, Cartilage Injury, Osteoarthritis, Knee
Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Arthroscopic synovial brushing
Microfracture
Sponsored by
About this trial
This is an interventional treatment trial for Defect of Articular Cartilage focused on measuring Cartilage, Mesenchymal stromal cell, Microfracture, Knee, Defect, Injury, Stem cell, Autologous, Minimally manipulated
Eligibility Criteria
Inclusion Criteria:
- Isolated cartilage defects (<2cm2)
- Patients undergoing microfracture for repair of cartilage defects
Exclusion Criteria:
- Septic arthritis
- Infectious disease
- Revision joint surgery
- Meniscal damage requiring repair
- Ligament damage requiring repair
- Cartilage defect greater than 2cm2
Contra-indications for MRI:
- Pacemakers, Implantable Cardioverter defibrillators, implantable cardiac loop recorders
- Surgical clips within the head
- Certain inner ear implants
- Neuro-electrical stimulators
- Metal fragments within the eye or head
Sites / Locations
- Chapel Allerton Orthopaedic Centre, Leeds Teaching Hospitals NHS TrustRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Control group
Intervention group
Arm Description
Patients in this group will received conventional microfracture treatment as indicated for isolated cartilage defects and defined by the inclusion criteria.
Patients in this group will also receive microfracture for the treatment of isolated cartilage defects in combination with arthroscopic synovial brushing to access and release synovial MSCs into the joint space.
Outcomes
Primary Outcome Measures
The mean change in the number of MSCs present in the knee pre- and post- microfracture/microfracture plus arthroscopic synovial brushing.
Secondary Outcome Measures
Number of patients whose clinical effusion scores improve at 3, 6 and 12 months
Number of patients whose semi-quantitative MRI cartilage scores improve at 6 and 12 months
Median KOOS scores at 3, 6 and 12 months (pain; other symptoms; function in daily living; function in sport; knee-related QoL; average score)
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Median WOMAC scores at 3, 6 and 12 months (total; pain; stiffness; function)
Visual Analogue Scale (VAS)
Full Information
NCT ID
NCT02696876
First Posted
February 26, 2016
Last Updated
April 27, 2021
Sponsor
University of Leeds
Collaborators
The Leeds Teaching Hospitals NHS Trust
1. Study Identification
Unique Protocol Identification Number
NCT02696876
Brief Title
Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair
Acronym
AURA
Official Title
Safety and Efficacy of a Novel Synovium Brushing Method for Endogenous Mesenchymal Stem Cells Mobilisation During Knee Joint Microfracture for Cartilage Repair.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 2017 (undefined)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
December 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Leeds
Collaborators
The Leeds Teaching Hospitals NHS Trust
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a proof-of-concept study to determine the safety and efficacy of a novel device to increase the reparative capacity of the knee. The discovery of a resident population of mesenchymal stem cells (MSCs) within synovial fluid (SF) was the first description of this reparative cell population having direct access to superficial cartilage and joint structures. The ready access of SF MSC to cartilage and other joint tissues offers a novel strategy for joint repair. Current arthroscopic procedures result in the removal of all SF MSCs due to continuous irrigation throughout the procedure. The current study would benefit the patient by greatly increasing the reparative capacity of the joint by bolstering MSC numbers and retaining those MSCs within the joint after surgery. By accessing MSCs from the synovium it is anticipated that these cells would be entrapped/migrate into the marrow clot formed by microfracture of the sub-chondral bone. These MSCs would supplement those from the marrow and may result in faster, better quality repair.
Detailed Description
The synovium is a rich source of potent chondrogenic mesenchymal stromal cells (MSCs). Gaining access to this valuable source of regenerative cells could improve the outcome of joint restorative procedures. To avoid costly two-stage procedures and ex vivo manipulation, exploiting these autologous cells in a minimally invasive way with minimal manipulation could provide a novel cost-effective approach.
This study will evaluate the safety, feasibility and efficacy of a novel medical device (a synovial brush) and procedure (synovial brushing) to increase the number of autologous minimally manipulated MSCs in the knee. Twenty patients undergoing microfracture for isolated chondral defects will be randomly assigned to either a control group (microfracture only, 10 patients) or the intervention group (microfracture plus synovial brushing, 10 patients). The device is intended to increase the number of MSCs within the joint as a final stage during surgery, aiding repair by bolstering those MSCs recruited from the bone marrow.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Defect of Articular Cartilage, Cartilage Injury, Osteoarthritis, Knee
Keywords
Cartilage, Mesenchymal stromal cell, Microfracture, Knee, Defect, Injury, Stem cell, Autologous, Minimally manipulated
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Patients in this group will received conventional microfracture treatment as indicated for isolated cartilage defects and defined by the inclusion criteria.
Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Patients in this group will also receive microfracture for the treatment of isolated cartilage defects in combination with arthroscopic synovial brushing to access and release synovial MSCs into the joint space.
Intervention Type
Device
Intervention Name(s)
Arthroscopic synovial brushing
Intervention Description
The specific and novel surgical procedure that will be carried out here is synovial membrane brushing using a novel device that has been shown to release MSCs from the synovium in vitro. This technique will be carried out in the setting of therapeutic microfracture for cartilage defects.
Intervention Type
Procedure
Intervention Name(s)
Microfracture
Other Intervention Name(s)
Marrow-stimulation
Intervention Description
Microfracture or marrow-stimulation is a surgical procedure to repair small isolated cartilage defects by recruiting bone marrow mesenchymal stromal cells by creating small holes ('micro fractures') in the sub-chondral bone. These cells are entrapped in the ensuing blood clot and contribute to partial repair of the cartilage.
Primary Outcome Measure Information:
Title
The mean change in the number of MSCs present in the knee pre- and post- microfracture/microfracture plus arthroscopic synovial brushing.
Time Frame
2 weeds
Secondary Outcome Measure Information:
Title
Number of patients whose clinical effusion scores improve at 3, 6 and 12 months
Time Frame
3, 6 and 12 months
Title
Number of patients whose semi-quantitative MRI cartilage scores improve at 6 and 12 months
Time Frame
up to 12 months
Title
Median KOOS scores at 3, 6 and 12 months (pain; other symptoms; function in daily living; function in sport; knee-related QoL; average score)
Time Frame
3, 6 and 12 months
Title
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Description
Median WOMAC scores at 3, 6 and 12 months (total; pain; stiffness; function)
Time Frame
3, 6 and 12 months
Title
Visual Analogue Scale (VAS)
Time Frame
3, 6 and 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Isolated cartilage defects (<2cm2)
Patients undergoing microfracture for repair of cartilage defects
Exclusion Criteria:
Septic arthritis
Infectious disease
Revision joint surgery
Meniscal damage requiring repair
Ligament damage requiring repair
Cartilage defect greater than 2cm2
Contra-indications for MRI:
Pacemakers, Implantable Cardioverter defibrillators, implantable cardiac loop recorders
Surgical clips within the head
Certain inner ear implants
Neuro-electrical stimulators
Metal fragments within the eye or head
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dennis G McGonagle, FRCPI PhD
Phone
0113 3924747
Email
d.g.mcgonagle@leeds.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Thomas G Baboolal, PhD
Phone
0113 3438413
Email
t.baboolal@leeds.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dennis G McGonagle, MB BcH BAO
Organizational Affiliation
University of Leeds
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chapel Allerton Orthopaedic Centre, Leeds Teaching Hospitals NHS Trust
City
Leeds
State/Province
West Yorkshire
ZIP/Postal Code
LS7 4SA
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Owen R Wall, MB ChB
First Name & Middle Initial & Last Name & Degree
Alam Khalil-Khan, MBBS
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair
We'll reach out to this number within 24 hrs